Physician profile
Sara Danker
NPI 1831432210
$5,900.73
in general payments reported to CMS, 2019-2025
21 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 75% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2021: $633 · 2022: $1,238 · 2023: $1,474 · 2024: $1,110 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,829.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,100.23 | 2019-2022 | |
| Mentor Worldwide LLC | $758.88 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $589.34 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Dilon Technologies, INC. | $476.44 | 2023-2024 | Hemoblast Bellows |
| Musculoskeletal Transplant Foundation INC. | $444.28 | 2025 | |
| Acera Surgical, INC. | $361.47 | 2022-2023 | Restrata Wound Matrix |
| Davol INC. | $310.64 | 2022-2025 | Phasix Mesh |
| Motiva USA, LLC | $303.93 | 2025 | |
| Axogen | $295.48 | 2023 | Avance Nerve Graft |
| Polynovo North America LLC | $211.35 | 2022-2025 | Novosorb Btm |
| Mimedx Group, INC. | $196.16 | 2024 | |
| Stryker Corporation | $172.86 | 2023 | Spy-Phi System |
| Sientra, INC. | $146.94 | 2022 | |
| Kci USA, INC. | $131.03 | 2022-2023 | Prevena, Prevena Restor Bellaform |
| Checkpoint Surgical, INC | $101.03 | 2024 | Checkpoint Stimulators |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $97.20 | 2023 | |
| Baxter Healthcare | $71.86 | 2019-2024 | |
| Biotissue Holdings INC. | $43.16 | 2025 | |
| Coopersurgical, INC. | $38.17 | 2025 | Onetrac Lx |
| Kerecis Limited | $30.60 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kls-Martin L.P. | $19.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Danker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.